The Latin America, Middle East and Africa Point-of-care Ultrasound Market should witness market growth of 16.7% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 19,520.2 units, showcasing a growth of 18.9% (2023-2030).
POCUS devices are frequently employed as time-saving solutions that boost productivity while maximizing patient safety, particularly for older patients. POCUS devices are strongly advised for elderly patients because they have more problems and a greater death rate than younger patients. For instance, primary-care doctors can use POCUS devices to non-invasively assess older patients' urine incontinence, screen them for prostatic enlargement and aberrant aortic aneurysms (AAA) and assess their heart function in outpatient settings.
A continuous increase in the number of old-age netizens is augmenting the growth of the market as they are more susceptible to diseases. Additionally, it may alter patient outcomes, maximize procedural effectiveness, and reduce complications with minimal to no dissatisfaction, raising the demand for point-of-care ultrasound solutions.
Rising patient concerns about radiation protection and a rising desire for rapid bedside diagnostics data analysis fuel point-of-care ultrasound adoption. Diagnostic ultrasound manufacturers are becoming increasingly conscious of the importance of handheld units that enable doctors or other healthcare professionals to carry point-of-care ultrasound into every department of a hospital, doctor's office, or elsewhere. This is due to the quick development of portable and hand-carried systems.
The UAE government estimates that as of 2021, 11.809 percent of the population in the UAE have diabetes. One of the main indicators of the success of the UAE National Agenda 2021's world-class healthcare pillar is lowering the prevalence of diabetes. This increased chance of diabetes ulcers in the region. Diabetes can result in consequences, including peripheral vascular disease, which may hinder blood flow and cause diabetic foot ulcers to develop. In order to aid in the early detection and management of these problems, POCUS can be utilized to evaluate blood flow and detect vascular abnormalities in the lower extremities. Therefore, the demand for POCUS would increase along with the rise in diabetes prevalence. All of these factors are anticipated to contribute to the market's expansion.
The Brazil market dominated the LAMEA Point-of-care Ultrasound Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $61.5 Million by 2030. The Argentina market is showcasing a CAGR of 17.3% during (2023-2030). Additionally, The UAE market would register a CAGR of 16.4% during (2023-2030).
Based on End-user, the market is segmented into Hospitals, Clinics, and Others. Based on Product, the market is segmented into Cart-based, and Compact & Hand-held. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Alpinion Medical Systems Co., Ltd. (ILJIN Group), Hitachi, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Terason, Healcerion Co., Ltd., Edan Instruments, Inc. and Chilson Medical Technologies Co., Ltd.
POCUS devices are frequently employed as time-saving solutions that boost productivity while maximizing patient safety, particularly for older patients. POCUS devices are strongly advised for elderly patients because they have more problems and a greater death rate than younger patients. For instance, primary-care doctors can use POCUS devices to non-invasively assess older patients' urine incontinence, screen them for prostatic enlargement and aberrant aortic aneurysms (AAA) and assess their heart function in outpatient settings.
A continuous increase in the number of old-age netizens is augmenting the growth of the market as they are more susceptible to diseases. Additionally, it may alter patient outcomes, maximize procedural effectiveness, and reduce complications with minimal to no dissatisfaction, raising the demand for point-of-care ultrasound solutions.
Rising patient concerns about radiation protection and a rising desire for rapid bedside diagnostics data analysis fuel point-of-care ultrasound adoption. Diagnostic ultrasound manufacturers are becoming increasingly conscious of the importance of handheld units that enable doctors or other healthcare professionals to carry point-of-care ultrasound into every department of a hospital, doctor's office, or elsewhere. This is due to the quick development of portable and hand-carried systems.
The UAE government estimates that as of 2021, 11.809 percent of the population in the UAE have diabetes. One of the main indicators of the success of the UAE National Agenda 2021's world-class healthcare pillar is lowering the prevalence of diabetes. This increased chance of diabetes ulcers in the region. Diabetes can result in consequences, including peripheral vascular disease, which may hinder blood flow and cause diabetic foot ulcers to develop. In order to aid in the early detection and management of these problems, POCUS can be utilized to evaluate blood flow and detect vascular abnormalities in the lower extremities. Therefore, the demand for POCUS would increase along with the rise in diabetes prevalence. All of these factors are anticipated to contribute to the market's expansion.
The Brazil market dominated the LAMEA Point-of-care Ultrasound Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $61.5 Million by 2030. The Argentina market is showcasing a CAGR of 17.3% during (2023-2030). Additionally, The UAE market would register a CAGR of 16.4% during (2023-2030).
Based on End-user, the market is segmented into Hospitals, Clinics, and Others. Based on Product, the market is segmented into Cart-based, and Compact & Hand-held. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Koninklijke Philips N.V., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Alpinion Medical Systems Co., Ltd. (ILJIN Group), Hitachi, Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Terason, Healcerion Co., Ltd., Edan Instruments, Inc. and Chilson Medical Technologies Co., Ltd.
Scope of the Study
By End-user (Volume, Units, USD Million, 2019-2030)
- Hospitals
- Clinics
- Others
By Product (Volume, Units, USD Million, 2019-2030)
- Cart-based
- Compact & Hand-held
By Country (Volume, Units, USD Million, 2019-2030)
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation)
- Alpinion Medical Systems Co., Ltd. (ILJIN Group)
- Hitachi, Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Terason
- Healcerion Co., Ltd.
- Edan Instruments, Inc.
- Chilson Medical Technologies Co., Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Point-of-care Ultrasound Market by End User
Chapter 6. LAMEA Point-of-care Ultrasound Market by Product
Chapter 7. LAMEA Point-of-care Ultrasound Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- GE HealthCare Technologies, Inc.
- Koninklijke Philips N.V.
- FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation)
- Alpinion Medical Systems Co., Ltd. (ILJIN Group)
- Hitachi, Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Terason
- Healcerion Co., Ltd.
- Edan Instruments, Inc.
- Chilson Medical Technologies Co., Ltd.
Methodology
LOADING...
